Navigation Links
OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer

HOUSTON, Dec. 5, 2012 /PRNewswire/ -- Pamela Westbrook has been named Chief Financial Officer, Vice President Finance & Administration for OrthoAccel Technologies (OrthoAccel®). In this position, she will oversee a broad range of corporate matters, including investor relations, financial reporting, treasury and taxation, information technology and organizational development for the company's global operations.

Ms. Westbrook has over 25 years of experience in finance and administration, primarily in the medical device industry. For the past five years, she has provided financial consulting services for a number of privately-owned start-up medical device companies, including OrthoAccel.  Prior to that, she served as CFO at Cyberonics, Inc. and the Physicians Resource Group. In addition, she was Vice President, Finance for SulzerMedica USA, Inc, and Vice President, Controller for Sulzer Carbomedics, Inc. She also held a Director-level position with Intermedics, Inc.

She graduated Cum Laude in Business Administration – Accounting from the University of Texas, Austin, and has been certified by the Texas State Board of Public Accountancy.

"We are absolutely delighted to welcome someone as qualified, experienced and skilled as Pam to OrthoAccel," says OrthoAccel CEO Mike Lowe. "As our business continues to grow both domestically and internationally, it's essential for our progress to be guided by sound financial principals and insight. We're entirely confident that Pam will provide those benefits. It's great to have her on board."

Ms. Westbrook joins OrthoAccel at the company's new offices in Bellaire, located in the Houston-Sugar Land metro area.

About OrthoAccel® Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

OrthoAccel developed and sells AcceleDent™, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying precisely calibrated micropulses as a complement to existing orthodontic treatment. More information can be found at or requested via

SOURCE OrthoAccel Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
2. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
3. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
4. CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
5. Drug Discovery Technologies, BCC Research
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... While it’s often important to take certain medications during the ... Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL ... it eliminates the need to turn on a light when taking medication during the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of ... part of a disaster drill on October 3rd. , Apple Rehab participated with the ... as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
Breaking Medicine News(10 mins):